Related Experiment Video
Updated: May 3, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Spontaneous omental bleeding in the setting of dual anti-platelet therapy with ticagrelor
Victoria E Cheng1, Anne Oppermen1, Dinesh Natarajan1
1Department of Cardiology, Western Hospital, Gordon Street, Footscray, Melbourne, Australia.
Insights
A patient experienced an omental bleed after straining, despite no clear risk factors besides dual antiplatelet therapy. This case highlights a rare complication potentially linked to intra-abdominal pressure and antiplatelet use.
Area of Science:
- Cardiology
- Gastroenterology
- Vascular Surgery
Background:
- A 68-year-old man with a history of ST-elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) surgery presented with recurrent chest pain.
- Initial evaluation showed no acute ischemic changes on ECG, and symptoms resolved with nitrates.
Observation:
- The patient later developed severe left-sided abdominal pain and hypovolemic shock after straining.
- Abdominal computed tomography (CT) revealed an omental bleed, necessitating an emergency laparotomy.
Findings:
- The omental bleed was presumed to be associated with dual antiplatelet therapy (aspirin and ticagrelor) and potentially elevated intra-abdominal pressure from straining.
- No other significant risk factors for bleeding were identified.
Implications:
- This case underscores the potential for spontaneous omental bleeds as a rare complication in patients on dual antiplatelet therapy, particularly when combined with increased intra-abdominal pressure.
- Further investigation into the interplay between antiplatelet agents, intra-abdominal pressure, and gastrointestinal bleeding may be warranted.
Abstract:
A 68 year-old man, initially managed with primary percutaneous coronary intervention (PCI) to the right coronary artery (RCA) for an inferior ST elevation myocardial infarction (STEMI) with residual disease requiring coronary artery bypass graft surgery (CABG), re-presented with chest pain. There were no acute ischaemic changes on ECG and his pain settled with nitrates. A day later, he developed left sided abdominal pain and hypovolaemic shock after straining in the toilet. A subsequent computed tomography (CT) scan of his abdomen revealed an omental bleed. He proceeded to emergency laparotomy, recovered well, and was discharged on aspirin and clopidogrel. Apart from dual antiplatelet therapy with aspirin and ticagrelor, and presumed raised intra-abdominal pressure, there were no other identified risk factors for increased bleeding.
More Related Videos
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
11:18Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
Published on: April 2, 2013
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...